Literature DB >> 8085475

Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report.

A Iwanami1, A Sugiyama, N Kuroki, S Toda, N Kato, Y Nakatani, N Horita, T Kaneko.   

Abstract

To examine the clinical characteristics of methamphetamine (MAP) psychosis in Japan, we evaluated 104 patients with MAP psychosis (80 men and 24 women) admitted to the closed psychiatric units of Tokyo Metropolitan Matsuzawa Hospital between 1988 and 1991. There has recently been a steep increase in the number of admissions for MAP psychosis, reflecting the growth of the epidemic of MAP abuse in Japan. Although more than half of the patients were discharged within one month, 16 patients were hospitalized for more than 3 months. Most of the patients showed paranoid psychotic state similar to schizophrenia, consistent with previous reports. Despite the abstinence from MAP and antipsychotic medication, psychotic symptoms tended to persist in some of the patients. The etiological role of MAP psychosis in the development of long-lasting psychotic state was discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085475     DOI: 10.1111/j.1600-0447.1994.tb01541.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  31 in total

1.  Asian-americans, addictions, and barriers to treatment.

Authors:  Timothy W Fong; John Tsuang
Journal:  Psychiatry (Edgmont)       Date:  2007-11

Review 2.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

3.  Symptoms and course of psychosis after methamphetamine abuse: one-year follow-up of a case.

Authors:  Seyed Vahid Shariat; Adele Elahi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

4.  Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a native American community sample.

Authors:  David A Gilder; Ian R Gizer; Philip Lau; Cindy L Ehlers
Journal:  J Addict Med       Date:  2014 Jul-Aug       Impact factor: 3.702

Review 5.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

6.  Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.

Authors:  Kazuhiko Nakamura; Chih-Ken Chen; Yoshimoto Sekine; Yasuhide Iwata; A Anitha; El-Wui Loh; Nori Takei; Atsuko Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Katsuaki Suzuki; Yoshio Minabe; Kenji Tsuchiya; Kazuo Yamada; Masaomi Iyo; Norio Ozaki; Toshiya Inada; Nakao Iwata; Mutsuo Harano; Tokutaro Komiyama; Mitsuhiko Yamada; Ichiro Sora; Hiroshi Ujike; David M Ball; Takeo Yoshikawa; Shih-Ku Lin; Norio Mori
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

7.  Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.

Authors:  James J Mahoney; Rollin Y Hawkins; Richard De La Garza; Ari D Kalechstein; Thomas F Newton
Journal:  Gend Med       Date:  2010-10

Review 8.  Pharmacotherapy of methamphetamine addiction: an update.

Authors:  Ahmed Elkashef; Frank Vocci; Glen Hanson; Jason White; Wendy Wickes; Jari Tiihonen
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

Review 9.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11

10.  Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use.

Authors:  Richard A Rawson
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.